Both estrogen receptor subtypes, ERα and ERβ, prevent aldosterone-induced oxidative stress in VSMC via increased NADPH bioavailability

Biochemical and Biophysical Research Communications

Volumn 423, Issue 4, 2012, Pages 850-856

  Muehlfelder, Melanie ^a,b   Arias Loza, Paula Anahi ^a   Fritzemeier, Karl Heinrich ^c   Pelzer, Theo ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

17 Estradiol; Aldosterone; Glucose 6 phosphate dehydrogenase; Reactive oxygen species

Indexed keywords

ALDOSTERONE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE MICROSCOPY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL;

ALDOSTERONE; ANIMALS; BIOLOGICAL AVAILABILITY; CELLS, CULTURED; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADP; OXIDATIVE STRESS; PHOSPHOPROTEINS; RATS; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 84863843864     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.053     Document Type: Article

References (34)

1. Fuller P.J., Young M.J. Mechanisms of mineralocorticoid action. Hypertension 2005, 46:1227-1235.
2. Callera G.E., Touyz R.M., Tostes R.C., Yogi A., He Y., Malkinson S., Schiffrin E.L. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension 2005, 45:773-779.
3. Cachofeiro V., Miana M., de Las Heras N., Martin-Fernandez B., Ballesteros S., Fernandez-Tresguerres J., Lahera V. Aldosterone and the vascular system. J. Steroid Biochem. Mol. Biol. 2008, 109:331-335.
4. Keidar S., Kaplan M., Pavlotzky E., Coleman R., Hayek T., Hamoud S., Aviram M. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 2004, 109:2213-2220.
5. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
6. Kamata H., Hirata H. Redox regulation of cellular signalling. Cell. Signal. 1999, 11:1-14.
7. Poli G., Leonarduzzi G., Biasi F., Chiarpotto E. Oxidative stress and cell signalling. Curr. Med. Chem. 2004, 11:1163-1182.
8. Leopold J.A., Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1332-1340.
9. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
10. Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox Signal. 2008, 10:179-206.
11. Mendelsohn M.E., Karas R.H. Estrogen and the blood vessel wall. Curr. Opin. Cardiol. 1994, 9:619-626.
12. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999, 340:1801-1811.
13. R.C. Tostes, D. Nigro, Z.B. Fortes, M.H. Carvalho, Effects of estrogen on the vascular system, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica et al. 36 (2003) 1143-1158.
14. Sugioka K., Shimosegawa Y., Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 1987, 210:37-39.
15. Shwaery G.T., Vita J.A., Keaney J.F. Antioxidant protection of LDL by physiological concentrations of 17 beta-estradiol. Requirement for estradiol modification. Circulation 1997, 95:1378-1385.
16. Arias-Loza P.A., Hu K., Dienesch C., Mehlich A.M., Konig S., Jazbutyte V., Neyses L., Hegele-Hartung C., Fritzemeier K.Heinrich, Pelzer T. Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodeling in aldosterone salt-treated rats. Hypertension 2007, 50:432-438.
17. Fernandes D.C., Wosniak J., Pescatore L.A., Bertoline M.A., Liberman M., Laurindo F.R., Santos C.X. Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems. Am. j. Physiol. Cell Physiol. 2007, 292:C413-422.
18. Arias-Loza P.A., Muehlfelder M., Elmore S.A., Maronpot R., Hu K., Blode H., Hegele-Hartung C., Fritzemeier K.H., Ertl G., Pelzer T. Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease. Toxicol. Pathol. 2009, 37:969-982.
19. Milhausen M., Levy H.R. Evidence for an essential lysine in glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides. Eur. J. Biochem./FEBS 1975, 50:453-461.
20. Wenger N.K., Speroff L., Packard B. Cardiovascular health and disease in women. N. Engl. J. Med. 1993, 329:247-256.
21. Strehlow K., Rotter S., Wassmann S., Adam O., Grohe C., Laufs K., Bohm M., Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ. Res. 2003, 93:170-177.
22. Dantas A.P., Tostes R.C., Fortes Z.B., Costa S.G., Nigro D., Carvalho M.H. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002, 39:405-411.
23. Wing L.Y., Chen Y.C., Shih Y.Y., Cheng J.C., Lin Y.J., Jiang M.J. Effects of oral estrogen on aortic ROS-generating and -scavenging enzymes and atherosclerosis in apoE-deficient mice. Exp. Biol. Med. 2009, 234:1037-1046.
24. Nagata D., Takahashi M., Sawai K., Tagami T., Usui T., Shimatsu A., Hirata Y., Naruse M. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension 2006, 48:165-171.
25. Sun Y., Zhang J., Lu L., Chen S.S., Quinn M.T., Weber K.T. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am. J. Pathol. 2002, 161:1773-1781.
26. Park Y.M., Lim B.H., Touyz R.M., Park J.B. Expression of NAD(P)H oxidase subunits and their contribution to cardiovascular damage in aldosterone/salt-induced hypertensive rat. J. Korean Med. Sci. 2008, 23:1039-1045.
27. O. Pechanova, L. Jendekova, S. Vrankova, Effect of chronic apocynin treatment on nitric oxide and reactive oxygen species production in borderline and spontaneous hypertension, Pharmacological reports: PR 61 (2009) 116-122.
28. Pollak N., Dolle C., Ziegler M. The power to reduce. pyridine nucleotides-small molecules with a multitude of functions. Biochem. J. 2007, 402:205-218.
29. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. Glutathione metabolism and its implications for health. J. Nutrition 2004, 134:489-492.
30. Kirkman H.N., Galiano S., Gaetani G.F. The function of catalase-bound NADPH. J. Biol. Chem. 1987, 262:660-666.
31. Arner E.S., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem./FEBS 2000, 267:6102-6109.
32. Lu H., Burns D., Garnier P., Wei G., Zhu K., Ying W. P2X7 receptors mediate NADH transport across the plasma membranes of astrocytes. Biochem. Biophys. Res. Commun. 2007, 362:946-950.
33. Pandolfi P.P., Sonati F., Rivi R., Mason P., Grosveld F., Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 1995, 14:5209-5215.
34. Leopold J.A., Dam A., Maron B.A., Scribner A.W., Liao R., Handy D.E., Stanton R.C., Pitt B., Loscalzo J. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat. Med. 2007, 13:189-197.